-
786-556A proprietary mixture of Formaldehyde, EDTA and Blue Dextran that is designed for use in loading DNA samples onto denaturing polyacrylamide gels. Applications Loading DNA samples onto denaturing polyacrylamide gels
-
786-574A proprietary mixture of Formaldehyde, EDTA and Blue Dextran that is designed for use in loading DNA samples onto denaturing polyacrylamide gels. Applications Loading DNA samples onto denaturing polyacrylamide gels
-
786-557A proprietary mixture of Formaldehyde, EDTA and Blue Dextran that is designed for use in loading DNA samples onto denaturing polyacrylamide gels. Applications Loading DNA samples onto denaturing polyacrylamide gels
-
19626-1A selective CSF1R inhibitor (IC<sub>50</sub> = 1 nM) that inhibits CSF1-dependent proliferation (EC<sub>50</sub> = 67 nM in bone marrow-derived macrophages) blocks tumor progression and significantly improves survival in glioma-bearing mice as well
-
19626-10A selective CSF1R inhibitor (IC<sub>50</sub> = 1 nM) that inhibits CSF1-dependent proliferation (EC<sub>50</sub> = 67 nM in bone marrow-derived macrophages) blocks tumor progression and significantly improves survival in glioma-bearing mice as well
-
19626-5A selective CSF1R inhibitor (IC<sub>50</sub> = 1 nM) that inhibits CSF1-dependent proliferation (EC<sub>50</sub> = 67 nM in bone marrow-derived macrophages) blocks tumor progression and significantly improves survival in glioma-bearing mice as well
-
19626-50A selective CSF1R inhibitor (IC<sub>50</sub> = 1 nM) that inhibits CSF1-dependent proliferation (EC<sub>50</sub> = 67 nM in bone marrow-derived macrophages) blocks tumor progression and significantly improves survival in glioma-bearing mice as well
-
10155-1000A dual acting antithrombogenic agent inhibitor of TXA2 synthase (IC50 = 12 nM) acts as an TP receptor antagonist (IC50 = 1.1 nM).
-
10155-10000A dual acting antithrombogenic agent inhibitor of TXA2 synthase (IC50 = 12 nM) acts as an TP receptor antagonist (IC50 = 1.1 nM).
-
10155-5000A dual acting antithrombogenic agent inhibitor of TXA2 synthase (IC50 = 12 nM) acts as an TP receptor antagonist (IC50 = 1.1 nM).
-
19782-1An orally available PARP1 and PARP2 inhibitor (Kis = 1.2 and 0.85 nM, respectively) selectively targets tumor cells with BRCA1, BRCA2, or PTEN gene mutations and elicits antitumor activity in xenografted tumors.
-
19782-10An orally available PARP1 and PARP2 inhibitor (Kis = 1.2 and 0.85 nM, respectively) selectively targets tumor cells with BRCA1, BRCA2, or PTEN gene mutations and elicits antitumor activity in xenografted tumors.